I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Discovery of CMX990: A Potent SARS-CoV‑2 3CL Protease Inhib..:
N. G. R. Dayan Elshan
;
Karen C. Wolff
;
Laura Riva
...
doi:10.1021/acs.jmedchem.3c01938.s002. , 2024
Link:
https://doi.org/10.1021/acs.jmedchem.3c01938.s002
RT Journal T1
Discovery of CMX990: A Potent SARS-CoV‑2 3CL Protease Inhibitor Bearing a Novel Warhead
UL https://suche.suub.uni-bremen.de/peid=base-ftgriffithunifig:oai:figshare.com:article_25199347&Exemplar=1&LAN=DE A1 N. G. R. Dayan Elshan A1 Karen C. Wolff A1 Laura Riva A1 Ashley K. Woods A1 Gennadii Grabovyi A1 Katy Wilson A1 James Pedroarena A1 Sourav Ghorai A1 Armen Nazarian A1 Frank Weiss A1 Yuyin Liu A1 Wrickban Mazumdar A1 Lirui Song A1 Neechi Okwor A1 Jacqueline Malvin A1 Malina A. Bakowski A1 Nathan Beutler A1 Melanie G. Kirkpatrick A1 Amal Gebara-Lamb A1 Edward Huang A1 Vân T. B. Nguyen-Tran A1 Victor Chi A1 Shuangwei Li A1 Thomas F. Rogers A1 Case W. McNamara A1 Anil Kumar Gupta A1 Alireza Rahimi A1 Jian Jeffrey Chen A1 Sean B. Joseph A1 Peter G. Schultz A1 Arnab K. Chatterjee YR 2024 K1 Biochemistry K1 Medicine K1 Cell Biology K1 Genetics K1 Molecular Biology K1 Pharmacology K1 Immunology K1 Developmental Biology K1 Cancer K1 Mental Health K1 Hematology K1 Infectious Diseases K1 Virology K1 Space Science K1 Environmental Sciences not elsewhere classified K1 Biological Sciences not elsewhere classified K1 Chemical Sciences not elsewhere classified K1 oral drug candidate K1 marketed drug nirmatrelvir K1 fewer safety liabilities K1 compelling preclinical profile K1 attractive target due K1 2 therapeutic options K1 pro </ sup K1 develop novel sars K1 cmx990 </ b K1 vivo </ K1 vitro </ K1 novel warhead K1 novel sars K1 ready accessibility K1 primary cells K1 paxlovid ) K1 increased robustness K1 homology within K1 coronaviral family K1 2 3cl JF doi:10.1021/acs.jmedchem.3c01938.s002 LK http://dx.doi.org/https://doi.org/10.1021/acs.jmedchem.3c01938.s002 DO https://doi.org/10.1021/acs.jmedchem.3c01938.s002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)